Strides receives USFDA EIR for KRS Gardens, Bangalore facility Medical Dialogues Bureau31 March 2020 8:00 AM GMTBangalore: Strides Pharma Science Limited has announced that it has received the Establishment Inspection Report (EIR) for the inspection conducted by ...
Strides Pharma gets USFDA EIR for its Bangalore flagship facility Medical Dialogues Bureau27 March 2020 5:56 AM GMTBangalore: Strides Pharma has announced that the Company's flagship facility (KRS Gardens) in Bangalore which was inspected by the USFDA in March 2020,...
Strides Pharma Ranitidine tablets within acceptable NDMA limits, says USFDA Medical Dialogues Bureau4 Nov 2019 11:01 AM GMTNew Delhi: Drug firm, Strides Pharma recently announced that the USFDA issued a statement1 on November 1, 2019, providing an update with the latest...
Strides Pharma gets USFDA nod for generic version of Vesicare Tablets to treat overactive bladder Medical Dialogues Bureau28 Sep 2019 9:08 AM GMT'Solifenacin Succinate Tablet is a generic version of Vesicare Tablets, 5 mg and 10 mg, of Astellas Pharma US, Inc, ' Strides Pharma said.Bangalore:...
Strides Pharma suspends sale of Ranitidine tab in US Medical Dialogues Bureau27 Sep 2019 4:26 AM GMTNew Delhi: Strides Pharma Science on Friday suspended the sale of Ranitidine tablets after it received an information request from the US health...
Strides Pharma re-enters injectable biz by infusing Rs 280 crore for controlling stake in Stelis Biopharma Farhat Nasim21 Sep 2019 6:34 AM GMTBengaluru-based Strides has already invested USD 35 million (about Rs 245 crore) for a 43 per cent ownership in Stelis.New Delhi: Strides Pharma...
Strides Pharma infuses Rs 15.50 crore in Fairmed for 70pc stake Medical Dialogues Bureau12 Sep 2019 4:30 AM GMTThe company's step-down subsidiary Strides Pharma Global has acquired a majority stake in Fairmed Healthcare AG which has a portfolio of generic produc...
Strides Pharma acquires manufacturing plant in Florida for Rs 3.59 crore Farhat Nasim27 Aug 2019 9:00 AM GMT'Strides Pharma Inc has acquired the manufacturing facility under an asset purchase agreement with Micelle Biopharma Inc for a consideration of USD 0.5...
Strides Pharma found destroying, dumping drug production documents: USFDA Investigation Medical Dialogues Bureau20 July 2019 8:46 AM GMTIn the letter to Strides Pharma, the FDA didn't explain whether its inspectors often check scrap yards or shredding rooms for documents, or whether it ...
Strides to exit investment in Arrow Pharma for over Rs 2000 crore Medical Dialogues Bureau30 Jan 2019 4:00 AM GMT'Strides will receive AUD 300 million as upfront payment at the closure of the transaction, while the balance AUD 94 million to be deferred through a s...
Strides Pharma Science to get Rs 147 Crore funding for consumer healthcare business Medical Dialogues Bureau2 Nov 2018 6:27 AM GMTThe agreement also envisages Strides Consumer Pvt Ltd to become a fully owned subsidiary of Strides Global Consumer Healthcare Ltd at a later date, sub...
